Drug Database
PH

Pharmaprojects No. 3498

✓ Approved

Southern Research Institute · POLA1 · 小分子

什么是 Pharmaprojects No. 3498?

Pharmaprojects No. 3498 是一种小分子,由Southern Research Institute研发。该药已获批,用于治疗相关适应症,给药途径:Unknown。

药物档案

公司Southern Research Institute
药物类别小分子
分子靶点POLA1, POLB
给药途径Unknown
状态Approved

作用机制

分子靶点

Pharmaprojects No. 3498 作用于 2 个分子靶点:

POLA1DNA polymerase alpha 1, catalytic subunit (PDR, POLA)
POLBDNA polymerase beta ()
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

Pharmaprojects No. 3498 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Neoplasms benign, malignant and unspecified (incl cysts and polyps)Hairy cell leukaemia✓ Approved

相关研究文献

PubMedCureus2026-10-26

Conservatively Managed Osteochondral Lesion of the Talus With a Subchondral Cyst: A Case Report.

Kiribayashi Toshiaki T, Seki Hayato H, Ueno Taiki T, Yoshimoto Takuma T et al.

Osteochondral lesions of the talus (OLT) are increasingly recognized as resulting from trauma in a broad sense, including repetitive microtrauma, yet detailed reports of lesions accompanied by a subchondral bone cyst that are managed conservatively alone remain scarce, and no consensus exists regarding their optimal management. We report the case of a 59-year-old woman with chronic right ankle pain that had not improved despite prior follow-up and who had no clear history of trauma. Examination revealed no swelling, tenderness, or pain on supination. Plain radiography and MRI demonstrated a subchondral cystic lesion with bone marrow edema on the medial talar dome, corresponding to a Scranton stage V, Anderson stage IIA osteochondral lesion. Given tolerable symptoms, small cyst size, and absence of cartilage damage on MRI, conservative management with outpatient observation was planned; however, the patient did not return for scheduled follow-up. She re-presented after a prolonged interval, and follow-up radiography showed no significant progression of the lesion. Although follow-up imaging in this case showed no significant progression of the lesion, prior literature indicates that radiographic progression can occur even in patients with favorable clinical symptoms, underscoring the importance of sustained clinical and radiographic follow-up in patients with OLT managed conservatively, even when early symptoms and imaging appear reassuring.

PMID 42928749
阅读全文 →
PubMedCureus2026-10-26

Association Between Patient Body Mass Index and Preferred Interpersonal Distance From Pharmacists.

Yamagiwa Haruno H, Gocho Saori S, Miyagi Yukina Y, Miyachi Yuka Y et al.

Appropriate interpersonal distance is an important element of nonverbal communication during medication counseling by pharmacists. Although interpersonal distance can be influenced by several factors such as sex, age, and psychological condition, the relationship between patients' body mass index (BMI) and their preferred interpersonal distance from pharmacists remains unclear. This study aimed to examine the association between patients' BMI and their preferred interpersonal distance from pharmacists. A total of 95 outpatients receiving anticancer drug therapy at the Nagoya Ekisaikai Hospital participated in this study. The preferred interpersonal distance was measured using both approach and withdrawal methods. The participants were divided into two groups according to their BMI: < 25 kg/m² and ≥ 25 kg/m². The preferred interpersonal distances of the two groups were then compared. Additional analyses were conducted to examine the combined effects of BMI, sex, and age. No significant difference in the preferred interpersonal distance was found between the two BMI groups. The combined analysis of sex and BMI also showed no statistically significant differences, although a possible trend was observed among the groups (p = 0.06). Similarly, no significant differences were identified in the combined analysis of age and BMI. No statistically significant association between BMI and preferred interpersonal distance was identified in this sample. However, the possible relationship between sex and BMI should be examined further in studies with larger sample sizes.

PMID 42928722
阅读全文 →
PubMedPolish archives of internal medicine2026-10-26

Contrast-enhanced mammography in a man with mixed invasive lobular and no-special-type breast carcinoma.

Rudnicki Wojciech W, Szpor Joanna J, Popiela Tadeusz T, Hodorowicz-Zaniewska Diana D et al.

PMID 42929490
阅读全文 →
PubMedActas espanolas de psiquiatria2026-10-26

Informing Your Future Clozapine Patients of the Mortality Risk: Fear of Agranulocytosis vs. Pharmacovigilance Fatal Outcomes.

de Leon Jose J, Ruan Can-Jun CJ, Schoretsanitis Georgios G, Sanz Emilio J EJ et al.

No abstract present.

PMID 42928661
阅读全文 →
PubMedGels (Basel, Switzerland)2026-10-26

Maternal, Embryofetal and Teratogenic Toxicity of Gel-Forming Galactomannan from Cassia grandis in Wistar Rats.

Nunes Daniel Medeiros DM, Oliveira André Luís Salvino Alves de ALSA, Oliveira Alisson Rodrigo da Silva ARDS, Soares Anísio Francisco AF et al.

This study aimed to evaluate the potential maternal and developmental toxicity of orally administered galactomannan extracted from Cassia grandis seeds during the pre-implantation and organogenesis periods in Wistar rats. Considering the promising biotechnological potential of this gel-forming polysaccharide, its safety evaluation during pregnancy is essential. In vitro analysis using the MTT assay demonstrated that galactomannan (1-10 µg/mL) was not cytotoxic to L929 fibroblasts. In vivo, pregnant rats treated with 0.1, 1.0, or 10 mg/kg showed no clinical signs of maternal toxicity, including alterations in behavior, body weight gain, or food or water intake. Additionally, no alterations were observed in the absolute or relative weights of maternal organs. During the pre-implantation phase, no differences were observed in the number of corpora lutea, implantation sites, or pre-implantation losses. Histological analyses of implantation sites and placentas revealed normal morphology in all groups. Exposure during organogenesis did not induce external, visceral, or skeletal malformations, and no significant changes were detected in reproductive parameters. A significant overall difference in fetal body weight was observed with a significant pairwise difference only between the 0.1 and 10 mg/kg groups; however, neither group differed significantly from the control. In conclusion, the oral administration of C. grandis galactomannan at the tested doses did not produce maternal, embryotoxic, or teratogenic effects in Wistar rats. However, further studies involving broader dose ranges, larger sample sizes, and formulation-specific assessments are necessary before conclusions regarding reproductive safety in biomedical applications can be established.

PMID 42929970
阅读全文 →
PubMedDentistry journal2026-10-26

No Evidence of Sexual Dimorphism in Third Molar Agenesis Patterns: A Cross-Sectional Study of Orthodontic Patients.

Ortner Nikola Sophie NS, Schnegelsberg Philipp Albert PA, Proff Peter P, Beisel-Memmert Svenja S et al.

Background/Objectives: Sexual dimorphism has been reported in several dental traits; however, its relevance in third molar agenesis (TMA) remains unclear. Methods: A cross-sectional retrospective study evaluated panoramic radiographs of German orthodontic patients. TMA was diagnosed using panoramic radiographs by evaluating the presence or absence of the third molars in all four quadrants of the jaws. Absence of third molar development was classified as agenesis. To ensure accuracy, diagnosis was established only in patients older than 12 years. The control group included only individuals with 32 teeth. Chi-square test was used to compare prevalence among groups. The number of TMA did not meet the assumption of normality according to the Shapiro-Wilk test, so group comparisons were performed using the Mann-Whitney U test (alpha  =  5%). Results: A total of 484 individuals were included (244 females, 240 males). TMA was present in 117 patients (59 females, 58 males). No sexual dimorphism or sex-specific differences in laterality were observed (p > 0.05). In total, 50 patients had one missing third molar, 35 patients had two missing third molars, 12 patients had three missing third molars, and 20 patients had four missing third molars. The mean number of missing third molars was 1.97 (standard error 0.16) in females and 1.88 (standard error 0.13) in males, with no significant difference between sexes (p = 0.69). Conclusions: TMA presents no sexual dimorphism as observed in other types of dental agenesis. These findings suggest that sex is unlikely to be a major factor in TMA.

PMID 42930397
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Pharmaprojects No. 3498